As NHS England’s consultation on the Commercial Framework closes, Cancer52 along with the following patient organisations; Blood Cancer Alliance, Fifth Sense, Charity Access to Medicines Coalition (CMAC), EOS Network, Sinus UK, and Prurigo Nodularis International have jointly signed a statement.
The statement asks for a more comprehensive and patient centred approach in the NHS Commercial Framework.
26th September 2024
コメント